Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,531.50
Bid: 1,530.50
Ask: 1,531.50
Change: 5.50 (0.36%)
Spread: 1.00 (0.065%)
Open: 1,537.00
High: 1,541.50
Low: 1,527.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Tampering in some US bottles of weight-loss drug Alli - Glaxo

Wed, 26th Mar 2014 21:09

(Updates with company statement, paragraphs 4-7)

March 26 (Reuters) - Some bottles of Alli, GlaxoSmithKlinePlc's weight-loss drug sold over the counter in theUnited States, have been tampered with, and the Food and DrugAdministration was investigating, the company said on Wednesday.

Consumers have reported that about 20 bottles bought instores in seven mostly Southern states contained products otherthan the drug, GlaxoSmithKline said.

The company said the affected bottles from five lots of thedrug could contain tablets and capsules of different shapes andcolors. The actual drug is colored turquoise. The bottles couldbe unlabeled and the lot numbers might not match the numbers onthe carton, GlaxoSmithKline said.

Glaxo spokeswoman Deborah Bolding said that so far therehave been no reports of serious illness related to the products.The company has advised anyone who did take pills found to comefrom packages that had been tampered with to contact theirdoctor.

"We are doing an investigation to determine any furtheraction," she said in a telephone interview.

FDA spokeswoman Tara Goodin confirmed by phone that theregulatory agency was also investigating the tampering.

Alli, which is sold by Glaxo's consumer healthcare business,is approved for use without a prescription for overweightadults, in conjunction with a low-fat diet.

Glaxo said the affected bottles were found in Alabama,Florida, Louisiana, Mississippi, New York, North Carolina andTexas. (Reporting By Vrinda Manocha and Deena Beasley; Editing by TedKerr and Jonathan Oatis)

More News
3 May 2023 09:19

Haleon not surprised by Pfizer stake sale plans, says CFO

LONDON, May 3 (Reuters) - Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday.

Read more
3 May 2023 07:09

Haleon Q1 profit misses analyst expectations

LONDON, May 3 (Reuters) - Haleon, the world's biggest standalone consumer health business, on Wednesday reported first-quarter profit below analyst expectations.

Read more
29 Apr 2023 15:45

US FDA panel backs restricted use of AstraZeneca's prostate cancer drug

April 28 (Reuters) - A panel of U.S. Food and Drug Administration advisers on Friday voted for the restricted use of British drugmaker AztraZeneca Plc's experimental treatment, jointly developed with Merck & Co, for a type of prostate cancer.

Read more
27 Apr 2023 10:39

GSK gets positive EU opinion for respiratory syncytial virus vaccine

(Alliance News) - GSK PLC on Thursday said its respiratory syncytial virus vaccine candidate has gained positive opinion from the European Medicines Agency body.

Read more
27 Apr 2023 10:39

IN BRIEF: Schroders taps PwC exec as CFO, GSK CFO as non-exec director

Schroders PLC - London-based investment manager - Hires Richard Oldfield to succeed Richard Keers as chief financial officer and an executive director. Oldfield currently is vice chair & global markets leader at accountants PricewaterhouseCoopers. Oldfield will join Schroders on October 2, and Keers will depart on December 31 after 10 years with the company. At Schroders, Oldfield will be responsible for "firm-wide operations" and for "financial management, risk management, technology, capital and treasury".

Read more
27 Apr 2023 08:16

EMA adopts 'positive opinion' of GSK's RSV vaccine candidate

(Sharecast News) - GSK updated the market on its respiratory syncytial virus (RSV) vaccine candidate for older adults on Thursday, reporting that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) had adopted a positive opinion by consensus.

Read more
26 Apr 2023 20:21

GSK's RSV vaccine first to get EU regulator's nod

EMA recommends authorization of first RSV vaccine

*

Read more
26 Apr 2023 17:48

European shares fall as healthcare stocks hit by drug reforms

Healthcare index marks biggest decline in 15 months

*

Read more
26 Apr 2023 17:03

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight.

Read more
26 Apr 2023 15:52

UK shareholder meetings calendar - next 7 days

Thursday 27 April 
Admiral Group PLCAGM
AFC Energy PLCAGM
Alliance Trust PLCAGM
AstraZeneca PLCAGM
BP PLCAGM
CLS Holdings PLCAGM
CRH PLCAGM
Dalata Hotel Group PLCAGM
Dial Square Investments PLCAGM
F&C Investment Trust PLCAGM
Flutter Entertainment PLCAGM
Gresham House Renewable Energy VCT 1 PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
Helios Towers PLCAGM
Ibstock PLCAGM
International Personal Finance PLCAGM
Kerry Group PLCAGM
London Stock Exchange Group PLCAGM
Pershing Square Holdings LtdAGM
Quixant PLCAGM
Robert Walters PLCAGM
Schroders PLCAGM
Serco Group PLCAGM
STV Group PLCAGM
Synectics PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Weir Group PLCAGM
Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
26 Apr 2023 14:12

EU publishes proposed drug laws overhaul, seting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

Read more
26 Apr 2023 13:24

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as HIV and respiratory medicines.

Read more
26 Apr 2023 12:03

EU publishes proposed drug laws overhaul, setting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

Read more
26 Apr 2023 09:21

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines.

Read more
26 Apr 2023 09:00

TOP NEWS: GSK quarterly sales and profit slips; confirms outlook

(Alliance News) - Brentford, London-based GSK PLC on Wednesday reported a slip in quarterly sales, but confirmed its 2023 guidance.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.